Filing Details
- Accession Number:
- 0001209191-14-012009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-19 19:11:55
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-02-19
- Accepted Time:
- 2014-02-19 19:11:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Evp Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-14 | 7,000 | $2.88 | 320,643 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-14 | 7,000 | $27.38 | 313,643 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-15 | 672 | $27.62 | 312,971 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-15 | 756 | $27.62 | 312,215 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-15 | 627 | $27.62 | 311,588 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2014-02-14 | 7,000 | $0.00 | 7,000 | $2.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 41,348 | 2014-12-02 | No | 4 | M | Direct |
Footnotes
- This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 9, 2013.
- Represents weighted average sale price. Actual sale prices ranged from $27.14 to $27.62.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on February 15, 2014, and the 1/3 of the shares that vested on each of February 15, 2012 and 2013, net of withholding.
- Includes 5,700 restricted stock units awarded February 5, 2012, of which 1/3 of the shares vest on each of February 15, 2014 and 2015, and the 1/3 of the shares that vested on February 15, 2013, net of withholding.
- Includes 5,000 restricted stock units awarded July 25, 2013, of which 1/3 of the shares vest on each of February 15, 2014, 2015 and 2016.
- Includes 5,360 restricted stock units awarded January 28, 2014, of which 1/3 of the shares vest on each of February 15, 2015, 2016 and 2017.
- Includes 5,700 restricted stock units awarded February 5, 2012, of which 1/3 vest on February 15, 2015, and the 1/3 of the shares that vested on each of February 15, 2013 and 2014, net of withholding.
- Includes an aggregate of 10,594 shares of common stock issuable pursuant to previously reported restricted stock units awards that have not vested.
- The option became exercisable as to 25% of the shares on December 2, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
